Article ISI SCOPUS
Human Vaccines and Immunotherapeutics  (2015)

Cost-effectiveness analysis of a multicomponent meningococcal serogroup B vaccine in hypothetic epidemic situation in a middle-income country

Izquierdo, G; Torres, JP; Santolaya, ME; Valenzuela, MT; Vega, J; Chomali, M

Keywords: outbreak, cerebrospinal fluid, csf, gdp, meningococcal disease, cost-effectiveness analysis, neisseria meningitidis, gross domestic product, MD, meningococcal vaccine, Nmen, 4CMenB, Serogroup B meningococcal vaccine

Más información

Título según WOS: Cost-effectiveness analysis of a multicomponent meningococcal serogroup B vaccine in hypothetic epidemic situation in a middle-income country
Título según SCOPUS: Cost-effectiveness analysis of a multicomponent meningococcal serogroup B vaccine in hypothetic epidemic situation in a middle-income country
Título de la Revista: Human Vaccines and Immunotherapeutics
Volumen: 11
Número: 4
Editorial: Taylor and Francis Inc.
Fecha de publicación: 2015
Página de inicio: 875
Página final: 883
Idioma: English
DOI:

10.1080/21645515.2015.1010885
Notas: ISI, SCOPUS